<- Back to digest

Foot and Ankle International - 2026-09-10 - Journal Article

Motion-Preserving Salvage for Failed Total Ankle Arthroplasty or Talar AVN: Outcomes of Combined Total Ankle Arthroplasty with Custom 3D-Printed Total Talus Replacement.

Saggar R, Smith RM, Heidinger E, Yaldo OM, Hasselman CT, Hogan MV, Kline AJ

case seriesLOE IVn = 18Mean 36.8 months (±16.6)

Topics

foot ankle
PMID: 42720036DOI: 10.1177/10711007261471856View on PubMed ->

Key Takeaway

Combined TAA with custom 3D-printed total talus replacement achieved 100% radiographic osseointegration at mean 36.8 months, with a 33.3% complication rate and 11.1% reoperation rate including one below-knee amputation.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This retrospective case series evaluated TAA combined with custom 3D-printed total talus replacement (TAA-TTR) as motion-preserving salvage for talar component collapse after prior TAA or talar AVN with concurrent subtalar arthritis in 18 patients. All patients underwent concurrent subtalar arthrodesis with BMA concentrate and were followed for a mean of 36.8 months. Complication rate was 33.3%, reoperation rate 11.1%, one patient required BKA, yet all achieved radiographic osseointegration and transitioned to full weight-bearing at a mean of 46.9 days.

Key Limitation

Absence of validated patient-reported outcome measures (AOFAS, PROMIS, VAS pain) prevents any functional comparison to tibiotalocalcaneal arthrodesis or prior TAA revision series.

Original Abstract

BACKGROUND

Talar component collapse following total ankle arthroplasty (TAA) and talar avascular necrosis (AVN) with concurrent ankle arthritis represent challenging clinical scenarios. Traditional salvage with tibiotalocalcaneal arthrodesis sacrifices motion and has nonunion rates approaching 30%. This study evaluates outcomes of a motion-preserving salvage strategy: combined TAA with custom 3D-printed total talus replacement (TAA-TTR).

METHODS

We retrospectively reviewed consecutive patients who underwent TAA-TTR between September 2020 and December 2023. Indications included talar component collapse following prior TAA or talar AVN with ankle and subtalar arthritis. Subtalar arthrodesis was performed using 2 screws with use of bone marrow aspirate concentrate. Primary endpoint was complication rate; secondary endpoints included reoperations, radiographic assessments, and functional recovery milestones.

RESULTS

Eighteen patients (10 females, 8 males; mean age 57.8 ± 10.8 years) were analyzed at mean follow-up of 36.8 ± 16.6 months, after excluding 2 with <12 months' follow-up. Nine had talar AVN and 9 had failed TAA. The complication rate was 33.3% (95% CI: 15.2%-57.3%) (AVN group 44%, revision TAA group 22%). Six patients experienced complications: superficial surgical site infection (SSI) (1), deep SSI requiring debridement surgery (2), extensor hallucis longus rupture (1), nerve-related complication (1), and asymptomatic Chopart joint subluxation (1). Two patients required serial operations, including 1 below-knee amputation for persistent pain and infection. Reoperation rate was 11.1% (95% CI: 3.1%-32.8%). Patients achieved rapid functional recovery: controlled ankle motion boot transition at mean 19.9 days, full weight-bearing at mean 46.9 days, and regular footwear at mean 10.7 weeks. All patients achieved radiographic osseointegration of talar component to the calcaneus.

CONCLUSION

TAA-TTR represents a viable motion-preserving procedure in this challenging population. Although patients achieved relatively rapid functional recovery and transition to regular footwear, rigorous selection remains key. This approach demonstrates a manageable complication rate while addressing tibiotalar and subtalar pathology simultaneously.

LEVEL OF EVIDENCE

Level IV, retrospective case series.